Comment from Anonymous
AnonymousSupportAdvocacy
Summary: The Alliance for Cruelty Free Science submits a technical feasibility briefing advocating for a rapid, two-phase transition from animal-based research to human-relevant New Approach Methodologies (NAMs). They argue that the transition is technically feasible within 24 months due to mature technologies like AI, organoids, and VR, and provide a comprehensive framework for infrastructure conversion and workforce retraining.
Please consider the attached technical feasibility briefing from The Alliance for Cruelty Free Science (Linda Birr-Pixton) as supplemental material relevant to ongoing discussions regarding modernization of biomedical research and increased adoption of human-relevant New Approach Methodologies (NAMs).
What makes this document particularly valuable is that it does not simply advocate for reducing animal use — it presents a detailed operational and infrastructure-based transition framework for how this could realistically be accomplished at scale. The briefing synthesizes existing technologies and policy concepts into a cohesive modernization strategy addressing many of the practical barriers that are frequently cited as obstacles to transition.
The document discusses:
• phased transition planning and implementation timelines
• use of archived FAIR-compliant datasets to preserve historical scientific knowledge
• integration of AI, computational modeling, organoids, and organs-on-chips
• infrastructure conversion of animal facilities into NAM-centered research hubs
• reviewer and workforce training initiatives
• translational reliability and interspecies limitations
• institutional and funding incentives that may unintentionally slow innovation
• strategies to support researchers during modernization and retraining efforts
Whether or not one agrees with every proposed timeline or recommendation, I believe this briefing provides a thoughtful and unusually comprehensive systems-level framework that warrants serious review and consideration within future scientific and regulatory modernization discussions.
Thank you for your time and consideration.